Form 8-K - Current report:
SEC Accession No. 0001437749-24-027432
Filing Date
2024-08-21
Accepted
2024-08-21 08:00:13
Documents
18
Period of Report
2024-08-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20240820_8k.htm   iXBRL 8-K 25301
2 EXHIBIT 99.1 ex_716956.htm EX-99.1 10609
7 monologo.jpg GRAPHIC 3641
8 p01.jpg GRAPHIC 30388
9 p02.jpg GRAPHIC 42856
  Complete submission text file 0001437749-24-027432.txt   285327

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20240821.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20240821_def.xml EX-101.DEF 12188
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20240821_lab.xml EX-101.LAB 16397
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20240821_pre.xml EX-101.PRE 12458
20 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20240820_8k_htm.xml XML 3057
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 241227234
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)